Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1159/000369896 http://scihub22266oqcxt.onion/10.1159/000369896 C4513835!4513835!26285602     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Viszeralmedizin 2014 ; 30 (6): 394-400 Nephropedia Template TP {{tp|p=26285602|t=2014. Clinical Management of Acute Portal/Mesenteric Vein Thrombosis |pdf=|usr=}}{{26285602}} gab.com Text Clinical Management of Acute Portal/Mesenteric Vein Thrombosis JO: Viszeralmedizin http://www.kidney.de/pget.php?&tw=1&pmid=26285602 #FOAvip Background: Acute thrombosis of the portal vein (PV) and/or the mesenteric vein (MV) is a rare but potentially life-threatening disease. A multitude of risk factors for acute portal vein thrombosis (PVT)/mesenteric vein thrombosis (MVT) have been identified, including liver cirrhosis, malignancy, coagulation disorders, intra-abdominal infection/inflammation, and postoperative condition. Methods: This article analyses the treatment options for acute PVT/MVT. Results: Initially, the clinical management should identify patients with an intra-abdominal focus requiring immediate surgical intervention (e.g. bowel ischaemia). Subsequently, emphasis is placed on the recanalization of the PV/MV or at least the prevention of thrombus extension to avoid long-term complications of portal hypertension. Several therapeutic options are currently available, including anticoagulation therapy, local/systemic thrombolysis, interventional or surgical thrombectomy, and a combination of these procedures. Due to the lack of prospective randomized studies, a comparison between these therapeutic approaches regarding the efficacy of PV/MV recanalization is difficult, if not impossible. Conclusion: In patients with acute PVT/MVT, an individualized treatment based on the clinical presentation, the underlying disease, the extent of the thrombosis, and the patients' comorbidities is mandatory. Therefore, these patients should be considered for an interdisciplinary therapy in specialized centres with the option to utilise all therapeutic approaches currently available. Twit Text FOAVip Clinical Management of Acute Portal/Mesenteric Vein Thrombosis ????Viszeralmedizin http://www.kidney.de/pget.php?&tw=1&pmid=26285602 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26285602 #FOAvip English Wikipedia <ref>{{Cite pmid|26285602}}</ref> Clinical Management of Acute Portal/Mesenteric Vein Thrombosis #MMPMID26285602 Lang SA; Loss M; Wohlgemuth WA; Schlitt HJ Viszeralmedizin 2014[Dec]; 30 (6): 394-400 PMID26285602show ga Background: Acute thrombosis of the portal vein (PV) and/or the mesenteric vein (MV) is a rare but potentially life-threatening disease. A multitude of risk factors for acute portal vein thrombosis (PVT)/mesenteric vein thrombosis (MVT) have been identified, including liver cirrhosis, malignancy, coagulation disorders, intra-abdominal infection/inflammation, and postoperative condition. Methods: This article analyses the treatment options for acute PVT/MVT. Results: Initially, the clinical management should identify patients with an intra-abdominal focus requiring immediate surgical intervention (e.g. bowel ischaemia). Subsequently, emphasis is placed on the recanalization of the PV/MV or at least the prevention of thrombus extension to avoid long-term complications of portal hypertension. Several therapeutic options are currently available, including anticoagulation therapy, local/systemic thrombolysis, interventional or surgical thrombectomy, and a combination of these procedures. Due to the lack of prospective randomized studies, a comparison between these therapeutic approaches regarding the efficacy of PV/MV recanalization is difficult, if not impossible. Conclusion: In patients with acute PVT/MVT, an individualized treatment based on the clinical presentation, the underlying disease, the extent of the thrombosis, and the patients' comorbidities is mandatory. Therefore, these patients should be considered for an interdisciplinary therapy in specialized centres with the option to utilise all therapeutic approaches currently available. äClinical Management of Acute Portal/Mesenteric Vein Thrombosis (epmc).pdf DeepDyve Pubget Overpricing